Possibilities for the use of anakinra in COVID-19

Abstract

The use of anakinra cannot be currently recommended outside of clinical trials as pathogenetic treatment of “cytokine storm” in severe COVID-19.

Keywords

• коронавирус
• анакинра
• covid-19